BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8526888)

  • 21. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
    de Vries LB; Oostra BA
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome.
    Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T
    Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurodevelopmental (fragile X syndrome) and neurodegenerative (tremor/ataxia syndrome) disorders associated to the 'growth' of a gene].
    Castro-Volio I; Cuenca-Berger P
    Rev Neurol; 2005 Apr 1-15; 40(7):431-7. PubMed ID: 15849678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene.
    Steyaert J; Borghgraef M; Legius E; Fryns JP
    Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mouse model for the fragile X syndrome.
    Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
    Sharma D; Gupta M; Thelma BK
    Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element.
    Beilina A; Tassone F; Schwartz PH; Sahota P; Hagerman PJ
    Hum Mol Genet; 2004 Mar; 13(5):543-9. PubMed ID: 14722156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of the FMR1 CGG repeat in a Basque sample.
    Arrieta I; Gil A; Nuñez T; Telez M; Martinez B; Criado B; Lostao C
    Hum Biol; 1999 Feb; 71(1):55-68. PubMed ID: 9972098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-strand conformation polymorphism analysis in the FMR1 gene.
    Castellví-Bel S; Sánchez A; Badenas C; Mallolas J; Barceló A; Jiménez D; Villa M; Estivill X; Milà M
    Am J Med Genet; 1999 May; 84(3):262-5. PubMed ID: 10331603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X syndrome.
    Terracciano A; Chiurazzi P; Neri G
    Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):32-7. PubMed ID: 16010677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A deletion of 1.6 Kb proximal to the CGG repeat of the FMR1 gene causes fragile X-like psychological features.
    Wiegers AM; Curfs LM; Meijer H; Oostra B; Fryns JP
    Genet Couns; 1994; 5(4):377-80. PubMed ID: 7888141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of FMR1 hypermethylation in somatic cell heterokaryons.
    Stoyanova V; Rossetti S; VAN Unen L; Oostra BA; Hoogeveen AT
    FASEB J; 2004 Dec; 18(15):1964-6. PubMed ID: 15377638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobehavioral characteristics of CGG amplification status in fragile X females.
    Thompson NM; Gulley ML; Rogeness GA; Clayton RJ; Johnson C; Hazelton B; Cho CG; Zellmer VT
    Am J Med Genet; 1994 Dec; 54(4):378-83. PubMed ID: 7726212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragile X syndrome without CCG amplification has an FMR1 deletion.
    Gedeon AK; Baker E; Robinson H; Partington MW; Gross B; Manca A; Korn B; Poustka A; Yu S; Sutherland GR
    Nat Genet; 1992 Aug; 1(5):341-4. PubMed ID: 1302032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the fragile X syndrome.
    Knight SJ; Hirst MC; Davies KE
    Dis Markers; 1992; 10(1):1-5. PubMed ID: 1424438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel polymorphism in the FMR1 gene resulting in a "pseudodeletion" of FMR1 in a commonly used fragile X assay.
    Daly TM; Rafii A; Martin RA; Zehnbauer BA
    J Mol Diagn; 2000 Aug; 2(3):128-31. PubMed ID: 11229516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic diversity at the FMR1 locus in Mexican population.
    Rosales-Reynoso MA; Mendoza-Carrera F; Troyo-Sanromán R; Medina C; Barros-Núñez P
    Arch Med Res; 2005; 36(4):412-7. PubMed ID: 15950084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.